CanSino Biologics Inc Cash Flow Reinvestment Rate

Latest as of December 2021: 0.43x

CanSino Biologics Inc cash flow reinvestment rate. CanSino Biologics Inc (CJH) has a Cash Flow Reinvestment Rate of 0.43x as of December 2021, reinvesting €344.15 Million (capex €284.07 Million plus investments €-60.09 Million) from operating cash flow of €806.73 Million. Explore CJH operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.43x

(Capex + Investments) / Operating CF

Total Reinvested

€344.15 Million

Capex + Investments

Operating Cash Flow

€806.73 Million

EUR

Capital Expenditures

€284.07 Million

EUR

Cash Flow Reinvestment Rate of CanSino Biologics Inc (2021–2025)

Cash flow reinvestment rate of CanSino Biologics Inc from 2021 to 2025. Historical reinvestment intensity for CanSino Biologics Inc across 2 annual periods. Explore capital reinvestment ratio of CanSino Biologics Inc to see what proportion of operating cash flow is directed to capital expenditures.

CanSino Biologics Inc Cash Flow Reinvestment Rate by Year (2021–2025)

CanSino Biologics Inc cash flow reinvestment rate by year from 2021 to 2025. Year-by-year capital reinvestment analysis for CanSino Biologics Inc. For the full cash flow conversion analysis, see CJH cash flow metrics.

Year	Reinvestment Rate	Total Reinvested (EUR)	Operating CF	Capex	YoY Change
2025	10.78x	€839.60 Million	€77.86 Million	€243.90 Million	▲ +748.3%
2021	1.27x	€2.61 Billion	€2.05 Billion	€1.20 Billion	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow